Apellis Pharmaceuticals, Inc. Common Stock
Symbol: APLS (NASDAQ)
25.70
▼ (-1.31%) -0.340
Company Description:
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
Key Stats
- Today's Open: $25.945
- Today's High: $25.945
- Today's Low: $25.7
- Today's Volume: 2.07K
- Yesterday Close: $26.04
- Yesterday High: $26.87
- Yesterday Low: $26.01
- Yesterday Volume: 1.73M
- Last Min Volume: 215
- Last Min High: $25.7
- Last Min Low: $25.7
- Last Min VWAP: $25.7
Company Profile
- Name: Apellis Pharmaceuticals, Inc. Common Stock
- Website: https://www.apellis.com
- Listed Date: 2017-11-09
- Location: WALTHAM, MA
- Market Status: Active
- CIK Number: 0001492422
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.29B
- Round Lot: 100
- Outstanding Shares: 126.29M
- Asset Type: CS
RECENT FILINGS FOR APLS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 144 | View |
| 2025-09-10 | 4 | View |
| 2025-09-08 | 144 | View |
| 2025-09-08 | 144 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-09-02 | 4 | View |
| 2025-09-02 | 3 | View |
| 2025-08-29 | 4 | View |
| 2025-08-27 | 144 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-18 | 4 | View |
| 2025-07-18 | 4 | View |
| 2025-07-17 | 144 | View |
| 2025-07-16 | 4 | View |
| 2025-07-16 | 144 | View |
Latest News on APLS